Cedars-Sinai Experts Discuss Pros, Cons of New Alzheimer’s Drug

Cedars-Sinai patient care teams are preparing to offer lecanemab, a new Alzheimer’s disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.